The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9181187, Compound G ID: ALA3985387
Chembl Id: CHEMBL3985387
PubChem CID: 10144088
Max Phase: Preclinical
Molecular Formula: C25H25F3N2O5S2
Molecular Weight: 554.61
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1csc(S(=O)(=O)N(CC(C)C)c2ccc(C(F)(F)F)cc2OCc2ccc(/C=C/C(=O)O)cc2)n1
Standard InChI: InChI=1S/C25H25F3N2O5S2/c1-16(2)13-30(37(33,34)24-29-17(3)15-36-24)21-10-9-20(25(26,27)28)12-22(21)35-14-19-6-4-18(5-7-19)8-11-23(31)32/h4-12,15-16H,13-14H2,1-3H3,(H,31,32)/b11-8+
Standard InChI Key: SLHKHBZSGXVQFX-DHZHZOJOSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 554.61Molecular Weight (Monoisotopic): 554.1157AlogP: 6.00#Rotatable Bonds: 10Polar Surface Area: 96.80Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.82CX Basic pKa: ┄CX LogP: 6.01CX LogD: 2.76Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.31Np Likeness Score: -1.16
References 1. (2015) Therapeutic agent for urinary excretion disorder,